Navigation Links
Bioprosthesis in Medical News

ATS Medical Announces First Commercial Implants of the ATS 3f Aortic Bioprosthesis in the United States

MINNEAPOLIS, Nov. 24 /PRNewswire-FirstCall/ -- ATS Medical, Inc. (Nasdaq: ATSI ), manufacturer and marketer of state-of-the-art cardiac surgery products and services, today announced that the first three commercial implants of the ATS 3f(R) Aortic Bioprosthesis were completed by Dr. Allan Stewar...

ATS Medical Announces Australian Regulatory Approval for ATS 3f Aortic Bioprosthesis

MINNEAPOLIS, Feb. 5 /PRNewswire-FirstCall/ -- ATS Medical, Inc. (Nasdaq: ATSI ), manufacturer and marketer of state-of-the-art cardiac surgery products and services, announced today that the Australian Therapeutic Goods Administration (TGA) has granted approval for commercialization of the A...

ATS Medical Announces FDA Approval of the ATS 3f Aortic Bioprosthesis

MINNEAPOLIS, Oct. 30 /PRNewswire-FirstCall/ -- ATS Medical, Inc. (Nasdaq: ATSI ), manufacturer and marketer of state-of-the-art cardiac surgery products and services, today announced it has received U.S. Food and Drug Administration (FDA) approval for the ATS 3f(R) Aortic Bioprosthesis. (Lo...

ATS Medical Provides Update on Clinical Progress of ATS 3f Enable Aortic Bioprosthesis

MINNEAPOLIS, Nov. 28 /PRNewswire-FirstCall/ -- ATS Medical Inc. (Nasdaq: ATSI ), manufacturer and marketer of state-of-the-art cardiac surgery products and services, today announced that a total of 47 patients have now undergone aortic valve replacement with its sutureless ATS 3f Enable(TM) A...

ATS Medical Announces Second Quarter 2009 Results

...erlin presented five-year single center follow-up data on the ATS 3F Aortic bioprosthesis highlighting the valve's excellent safety and performance profile. Dr... U.K. presented five-year hemodynamic performance data on the ATS 3F Aortic bioprosthesis as assessed by valve energy loss and pressure gradient. Dr. Jin's findings...

ATS Medical Announces Participation in the Joint Meeting of the Society for Heart Valve Disease and Heart Valve Society of America

...Five Year Hemodynamic Performance of ATS 3f Aortic bioprosthesis Assessed By Valve Energy Loss and Pressure Gradien...inical Experience with the ATS 3f Stentless Aortic bioprosthesis - Five Years Follow Up," Joerg Linneweber, M.D., K...ng the ATS exhibition will be the ATS 3f(R) Aortic bioprosthesis which is designed to replace the patient's disease...

ATS Medical Announces Participation in the International Society for Minimally Invasive Cardiothoracic Surgery Meeting

...of the ATS exhibition will be the ATS 3f(R) Aortic bioprosthesis which is designed to replace the patient's diseased valve. The ATS 3f Aortic bioprosthesis is a revolutionary next generation stentless peric.... By restoring this continuity, the ATS 3f Aortic bioprosthesis is the only aortic valve that preserves the sinuse...

ATS Medical Announces Participation in 45th Annual Society of Thoracic Surgeons Meeting

...volutionary next generation stentless pericardical aortic tissue valve that is unlike any other. Post-approval commercialization of the ATS 3f Aortic bioprosthesis continues with the valve's unique design and compelling clinical benefits generating enthusiasm and product demand among U.S. surgeons. The ATS...

ATS Medical Products Featured Prominently in Scientific Presentations at European Association for Cardio-Thoracic Surgeons (EACTS) Annual Meeting

...ic Bioprosthesis incorporates the ATS 3f(R) Aortic bioprosthesis on a Nitinol self-expanding frame which eliminates...ht several products including the ATS 3f(R) Aortic bioprosthesis and the new ATS CryoMaze(TM) Clamp. Based on the p...that 'Form Follows Function', the ATS 3f(R) Aortic bioprosthesis is a revolutionary stentless pericardial aortic ti...

ATS Medical Products Prominently Featured in International Society for Minimally Invasive Cardiothoracic Surgery (ISMICS) Scientific Presentations

... surgical procedures for the treatment of atrial fibrillation that can improve efficacy while reducing the risk profile. The ATS 3f Enable(R) Aortic bioprosthesis is currently in clinical trials in Europe and is designed to eliminate the traditional suturing now required when replacing a patient's diseased or de...
Bioprosthesis in Medical Products

Mosaic Aortic Bioprosthesis with CINCH Advanced Implant System

Description: Mosaic, the third generation tissue valve from Medtronic, is the only third generation stented tissue valve available. The Mosaic valve builds upon three decades of tissue valve experience and is an excellent choice for patients who require aortic or mitral valve replacement with a tissue valve. Fo...
Company:Medtronic Inc.

Hancock® Standard Mitral Bioprosthesis

Description: The Hancock Standard Mitral bioprosthesis is a portrait of dependability, with predictable results based on 25 years of clinical use. Documented long-term performance makes it an excellent choice for patients requiring mitral valve replacement--particularly elderly patients and those with coronary ...
Company:Medtronic Inc.

Hancock II Aortic Bioprostheses with CINCH Advanced Implant System

Description:... The Hancock II bioprosthesis from Medtronic has more than 15 years of proven clinical experience. Worldwide clinical studies demonstrate that the freedom from structural valve det...
Company:Medtronic Inc.

Hancock® II Aortic Bioprostheses

Description:... The Hancock® II bioprosthesis from Medtronic has more than 15 years of proven clinical experience. Worldwide clinical studies demonstrate that the freedom from structural valve det...
Company:Medtronic Inc.

Hancock® II Mitral Bioprostheses

Description:... The Hancock® II bioprosthesis from Medtronic has more than 15 years of proven clinical experience. Worldwide clinical studies demonstrate that the freedom from structural valve det...
Company:Medtronic Inc.
Bioprosthesis in Biological Technology

ATS Medical Provides Update on US Commercialization of Its ATS 3f Aortic Bioprosthesis

MINNEAPOLIS, Dec. 8 /PRNewswire-FirstCall/ -- ATS Medical, Inc. (Nasdaq: ATSI ), manufacturer and marketer of state-of-the-art cardiac surgery products and services, today announced it has received FDA clearance for the marketing of the ATS 3f(R) Aortic Bioprosthesis that includes a new sewing t...

ATS Medical Announces First North American Commercial Implant of the ATS 3f Aortic Bioprosthesis

Follows Canadian regulatory approval of the ATS 3f Valve MINNEAPOLIS, April 10 /PRNewswire-FirstCall/ -- ATS Medical, Inc. (Nasdaq: ATSI ), manufacturer and marketer of state-of-the-art cardiac surgery products and services, today announced the first North American commercial implant ...

ATS Medical Announces Participation in the Annual Meeting of the American Association for Thoracic Surgeons

...S's broad product offering is the ATS 3f(R) Aortic bioprosthesis designed to replace the patient's diseased valve. The ATS 3f Aortic bioprosthesis is a revolutionary next generation stentless peric.... By restoring this continuity, the ATS 3f Aortic bioprosthesis is the only aortic valve that preserves the sinuse...

ATS Medical Announces Record Quarterly Revenue and Gross Profit

...he ATS 3f Aortic Bioprosthesis. The Company submitted answers to the FDA in March 2008. Management continues to expect that the ATS 3f Aortic bioprosthesis will be approved in the second half of 2008. -- ATS 3f Enable(TM) Aortic Bioprosthesis: Enrollment continues to progress with excellent cli...
Other Tags
(Date:8/29/2014)... (PRWEB) August 29, 2014 The new review ... Miracle program is a holistic system that will permanently eliminate ... patients suffering from tinnitus can achieve a cure in as ... felt much sooner, in only about one week. , ... in overcoming symptoms such as mild hearing loss, pain in ...
(Date:8/29/2014)... The Nasal Polyps Treatment Miracle ... new program is actually based on some powerful ... by a former nasal polyps sufferer, who in ... problem. Manuel Richards suffered from nasal polyps for ... , Learn more about Manuel Richards' new book ...
(Date:8/29/2014)... Indosoft, Inc., a leading provider of ... monthly per-port licensing of its Q-Suite 5.7 software. ... Indosoft has been successfully deploying and supporting its ACD ... centers around the world for more than a decade. ... clients another option which complements the widespread deployment of ...
(Date:8/29/2014)... (PRWEB) August 29, 2014 Dr. Mohebi’s ... others who talked about introducing these cutting edge techniques ... chairman of the FUE Research Committee has allowed him ... redefine what is possible with modern technology. Dr. Mohebi ... variety of FUE devices that facilitate extraction and implantation ...
(Date:8/29/2014)... August 29, 2014 As reported by WKMS.com ... Recovery , an Ohio municipal court drug has come up ... Fred Moses, who serves as the presiding judge in a ... makers to offer addicts a medicated treatment option that can ... the drug known as Vivitrol, which blocks receptors in the ...
Breaking Medicine News(10 mins):Health News:Tinnitus Miracle Review Reveals How to Gain Tinnitus Relief in 7 Days 2Health News:Nasal Polyps Treatment Miracle Review Exposes New Natural and Permanent Healing Program 2Health News:Indosoft Offers Monthly Usage Licensing Terms 2Health News:Parsa Mohebi M.D., Beverly Hills Hair Restoration Surgeon Gives Inspiring Lecture on Groundbreaking Techniques in Follicular Unit Extraction 2Health News:Ohio Judge Pushes for Addiction Recovery Tool 2Health News:Ohio Judge Pushes for Addiction Recovery Tool 3
(Date:8/29/2014)... understand how the repeated climatic shifts over the ... of genetic diversity, a team of researchers led ... Ana Carnaval developed a new biodiversity metric called ... which the genetic variation within species is restricted ... professor of biology, and 14 other researchers from ...
(Date:8/29/2014)... news release is available in German . ... key players in the natural nitrogen cycle on Earth ... specialist bacteria were thought to depend on nitrite as ... led by Holger Daims, a microbiologist at the University ... use hydrogen as an alternative source of energy. The ...
(Date:8/29/2014)... as the prolific bloomer Emiliania huxleyi , can ... The finding contradicts the common view that E. ... scarce supplies of thiamine in the ocean to survive. ... the ocean," says CIFAR Senior Fellow Alexandra Worden ... with CIFAR fellows John Archibald (Dalhousie University), ...
Breaking Biology News(10 mins):CCNY team defines new biodiversity metric 2Hydrogen powers important nitrogen-transforming bacteria 2Hydrogen powers important nitrogen-transforming bacteria 3Not all phytoplankton in the ocean need to take their vitamins 2Not all phytoplankton in the ocean need to take their vitamins 3
Other Contents